Amoxapine

Amoxapine is a tricyclic antidepressant used in the treatment of neurotic or reactive depressive disorders and endogenous or psychotic depression. Amoxapine, the N-demethylated derivative of the antipsychotic agent loxapine, is a dibenzoxazepine-derivative tricyclic antidepressant (TCA).

Chemical structure of Amoxapine
Mechanism
Curator reviewed
Primary indication
For the relief of symptoms of depression in patients with neurotic or reactive depressive disorders as well as endogenous and psychotic depressions.Curator reviewed · 6 structured indications
Formula / weight
C17H16ClN3O · 313.781 g/mol (avg)
First approval
Canada, 1981 · United States, 1991
Also known as
Desmethylloxapin
Code names
CL-67,772

Resolves to

Structure
InChIKeyQWGDMFLQWFTERH-UHFFFAOYSA-NSMILESClC1=CC2=C(OC3=CC=CC=C3N=C2N2CCNCC2)C=C1

What you can answer from here — as of September 20, 2026

26Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
1,837Drug interactionsStructured to mechanism, not free text
Sign in
6Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
2ContraindicationsEach with its own population and attribute set
Sign in
17Marketed productsAcross 3 countries and 6 labellers
Sign in
1ATC codeIncluding every combination product, plus 53 drug categories
Sign in
65+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Amoxapine, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account